Figure 3 Molecular mechanisms of crystal-induced necroinflammation

Slides:



Advertisements
Similar presentations
Peter J. Barnes, FRS, FMedSci 
Advertisements

Hal M. Hoffman, MD, Lori Broderick, MD, PhD 
Mechanism of Action of Colchicine in the Treatment of Gout
Figure 2 Cell-mediated disease mechanisms of lupus nephritis
Figure 4 Interactions between adipose, the microbiome and kidney
Inna S. Afonina, Christina Müller, Seamus J. Martin, Rudi Beyaert 
Figure 1 Radiation-induced effects on tumour cells
The inflammasome in liver disease
Figure 4 Simplified T cell and antigen presenting
Figure 7 Overview of crystal deposition in the
Therapy of autoinflammatory syndromes
Figure 1 Inducers of the NLRP3 inflammasome related
NOD-like and Toll-like receptors or inflammasomes contribute to kidney disease in a canonical and a non-canonical manner  Hans-Joachim Anders, Maciej.
Nader Yatim, Matthew L. Albert  Immunity 
Nat. Rev. Nephrol. doi: /nrneph
Toll-like receptors in Borrelia burgdorferi-induced inflammation
Nat. Rev. Cardiol. doi: /nrcardio
Agnieszka Kaczmarek, Peter Vandenabeele, Dmitri V. Krysko  Immunity 
Hal M. Hoffman, MD, Lori Broderick, MD, PhD 
Figure 1 Activation and signalling of IL-1
Autoinflammatory Skin Disorders: The Inflammasome in Focus
Nat. Rev. Nephrol. doi: /nrneph
Figure 5 Mechanisms of crystal granuloma formation
Mechanism and Regulation of NLRP3 Inflammasome Activation
Nat. Rev. Nephrol. doi: /nrneph
Figure 1 The coagulation system
Dieter Demon, Lieselotte Vande Walle, Mohamed Lamkanfi 
Figure 2 Organ crosstalk in the pathophysiology
Transcriptional inflammatory response to hypoxia and cellular necrosis
Figure 3 Cascade of events leading from AKI to ALI
and obesity-related kidney diseases
ER stress-induced inflammation: does it aid or impede disease progression?  Abhishek D. Garg, Agnieszka Kaczmarek, Olga Krysko, Peter Vandenabeele, Dmitri.
Nat. Rev. Nephrol. doi: /nrneph
Benjamin L. Woolbright, Hartmut Jaeschke  Journal of Hepatology 
Figure 1 Mechanisms of neutrophil extracellular trap formation
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 3 Pathological activation of complement
Figure 4 Mechanisms of leptin function on kidney injury
Staying Alive: Cell Death in Antiviral Immunity
Ischemia-reperfusion injury in renal transplantation: 3 key signaling pathways in tubular epithelial cells  Stephanie F. Smith, Sarah A. Hosgood, Michael.
Diana Panayotova-Dimitrova, Maria Feoktistova, Martin Leverkus 
Figure 1 Principal pathogenic mechanisms of
Volume 146, Issue 7, Pages (June 2014)
Volume 70, Issue 7, Pages (October 2006)
Figure 1 NETosis pathways and potential therapeutic targets
Chengcheng Jin, Jorge Henao-Mejia, Richard A. Flavell  Cell Metabolism 
Anti-inflammatory Agents: Present and Future
Mechanism of steroid action in renal epithelial cells
Inflammasome Activation: How Macrophages Watch What They Eat
Figure 2 A model of TNFR–complex I signalling
An Inflammatory Perspective on Necroptosis
Figure 1 Sequence of events in the development of autoimmune nephritis
Inflammasomes in Intestinal Inflammation and Cancer
Roles of Caspases in Necrotic Cell Death
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 3 Bile acid-induced hepatic inflammation and carcinogenesis
Figure 1 NLRP3 inflammasome formation pathways
The mechanisms by which mitochondrial dysfunction in chronic obstructive pulmonary disease (COPD) lead to increased oxidative stress and inflammation,
Therapeutic strategies in inflammasome mediated diseases of the liver
Manipulation of Host Cell Death Pathways during Microbial Infections
Figure 2 Initiators of obesity-associated inflammation in adipocytes
Christoph Becker, Alastair J. Watson, Markus F. Neurath 
DNA Makes RNA Makes Innate Immunity
Mechanisms and Functions of Inflammasomes
A possible mechanism of renal cell death after ischemia/reperfusion
Paola Romagnani, Hans-Joachim Anders  Kidney International 
NODding off in acute kidney injury with progranulin?
Sachin P. Gadani, James T. Walsh, John R. Lukens, Jonathan Kipnis 
The End and After: How Dying Cells Impact the Living Organism
Presentation transcript:

Figure 3 Molecular mechanisms of crystal-induced necroinflammation Figure 3 | Molecular mechanisms of crystal-induced necroinflammation. Supersaturation of solutes in the urine leads to deposition of crystals in the tubular lumen, which activate signalling pathways that lead to tubular cell death (through necroptosis). Phagocytosis of crystals causes lysosomal destabilization and release of cathepsin B (cat-B), which cleaves receptor-interacting serine/threonine-protein kinase (RIPK) 1, a negative regulator of necroptosis. In conditions where caspase-8 is inhibited, RIPK1 degradation triggers the formation of the RIPK3–MLKL necrosome complex, resulting in tubular cell necroptosis. Dying tubular cells release numerous damage-associated molecular patterns (DAMPs) and alarmins, which initiate inflammation. Dendritic cells and macrophages phagocytose crystals present in the interstitial compartment. Subsequent lysosomal destabilization releases cat-B and reactive oxygen species (ROS), which activate the NLRP3 inflammasome and induce secretion of mature IL-1β by dendritic cells, triggering IL-1 receptor (IL-1R)-dependent inflammation in the kidney. The TNF receptor (TNFR) pathway can activate NF-κB, which contributes to the activation of the inflammasome. RIPK3 and MLKL can also activate the NLRP3 inflammasome but whether this process is triggered by crystals is still unknown. Certain proinflammatory cytokines such as TNF can trigger regulated necrosis in renal cells through the TNFR, leading to further DAMP release. This process leads to an auto-amplification loop of crystal-induced necroinflammation. DAMPs such as histones act as a central mediator of the necroinflammation loop as they induce both Toll-like receptor-dependent inflammation and charge-dependent cell necrosis. Mulay, S. R. & Anders, H.-J. (2017) Crystal nephropathies: mechanisms of crystal-induced kidney injury Nat. Rev. Nephrol. doi:10.1038/nrneph.2017.10